Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214862

Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Introduction: the diagnosis of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has increased significantly due to the widespread use of high-resolution imaging tests, which is why the most appropriate management at the time of diagnosis is the subject of debate, as is how to follow-up patients. Aims: the objective of this study was to analyze the frequency of imaging and endoscopic studies performed during long-term follow-up. Methods: a retrospective review was performed of a database collected between January 2008 and December 2020 of patients with an incidental diagnosis of small NF-PNETs; follow-up was closed in March 2023. The imaging tests performed at the time of diagnosis and long-term follow-up were recorded. Growing less than 1 mm per year has not been considered as a worrisome feature. Follow-up was performed through imaging tests, considering endoscopic cytology for lesions with a faster grow rate. Results: fifty-eight patients were included; the median age was 69 years. The initial mean size of the lesions studied was 12.79 mm (5-27). Follow-up was carried out only with computed tomography (CT) or magnetic resonance imaging (MRI). The initial size did not influence the behavior of the lesion in a statistically significant manner. Twenty-eight tumors (45 %) increased in size, with a growth equal to or less than 4 mm in 24 cases. The mean follow-up time was 82.41 months (12-164). No patient developed metastasis or died from PNET progression. Conclusions: the follow-up of neuroendocrine tumors of small size can be performed safely with only imaging tests.

Citació

Citació

POLETTE, Daniela, BUSQUETS BARENYS, Juli, SECANELLA MEDAYO, Luis, SORRIBAS GRIFELL, María, PELÁEZ SERRA, Nuria, URIBE, Catalina, MARTINEZ-CARNICERO, Laura, SALORD, Silvia, GUERRERO PÉREZ, Fernando, VERCHER CONEJERO, José luís, TEULÉ VEGA, Àlex, FABREGAT PROUS, Joan. Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?. _Revista Española de Enfermedades Digestivas_. 2024. Vol. 116, núm. 4, pàgs. 209-215. [consulta: 23 de gener de 2026]. ISSN: 1130-0108. [Disponible a: https://hdl.handle.net/2445/214862]

Exportar metadades

JSON - METS

Compartir registre